Liver cancer patients get double punch: radiation beads plus immunotherapy
NCT ID NCT05063565
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 30 times
Summary
This study tests a two-step treatment for liver cancer. First, tiny radioactive beads are injected into the liver to destroy tumors. Then, two immunotherapy drugs (durvalumab and tremelimumab) are given to help the immune system fight any remaining cancer. The goal is to see how well this combination shrinks tumors and to check for side effects. About 100 adults with liver cancer are taking part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Azienda Sanitaria Universitaria Integrata Friuli Centrale (ASU FC)
Udine, Italy
-
CHU Angers - Hôpital Hôtel Dieu
Nantes, 49033, France
-
CHU Grenoble
Grenoble, Isere, 38043, France
-
CHU Montpellier
Montpellier, 34295, France
-
CHU Nantes
Rennes, Cedex, 35042, France
-
CHU de Bordeaux - Hôpital Haut-Lévêque
Clermont-Ferrand, France
-
CRLCC Eugene Marquis
Rennes, France
-
Chru De Lille
Lille, 59037, France
-
Chu Henri Mondor
Créteil, 94010, France
-
Clinica Universidad de Navarra
Pamplona, Navarre, 31008, Spain
-
Clinico de Valladolid
Valladolid, 47012, Spain
-
Columbia University Irving Medical Center
New York, New York, 10032, United States
-
Georgetown University
Washington D.C., District of Columbia, 20007, United States
-
Hopital Paul Brousse
Villejuif, 94800, France
-
Hospital Clinic de Barcelona
Barcelona, Catalonia, 08036, Spain
-
Hospital Gregorio Maranon
Madrid, Spain
-
Hospital Universitari
Valencia, 46026, Spain
-
Hospital Universitario Central de Asturias
Oviedo, Principality of Asturias, 33006, Spain
-
Hospital Universitario Virgen de las Nieves
Madrid, Spain
-
Hospital. Ramon Y Cajal
Madrid, Spain
-
Hôpital Beaujon
Clichy, Hauts De Seine, 92110, France
-
IRCCS - Regina Elena Cancer Institute
Roma, Italy
-
Intermountain Health
Salt Lake City, Utah, 84157, United States
-
Mayo Clinic
Jacksonville, Florida, 32224, United States
-
MedStar Washington Hospital Center
Washington D.C., District of Columbia, 20010, United States
-
National Cancer Institute of Milan, Italy
Milan, 20133, Italy
-
Ochsner Clinic Foundation
New Orleans, Louisiana, 70121, United States
-
Rush University Medical Center
Chicago, Illinois, 60612, United States
-
University Hospital Geneva (HUG)
Geneva, 1211, Switzerland
-
University Hospital of Bern
Bern, 3010, Switzerland
-
University of Arizona- Banner Health
Tucson, Arizona, 85724, United States
-
University of California San Diego
San Diego, California, 92093, United States
-
University of California San Francisco
San Francisco, California, 94143, United States
-
University of Chicago Hospital
Chicago, Illinois, 60637, United States
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States
-
Washington University (Barnes-Jewish Hospital)
St Louis, Missouri, 63101, United States
Conditions
Explore the condition pages connected to this study.